The Human Oncoprotein MDM2 Arrests the Cell Cycle: Elimination of Its Cell-cycle-inhibitory Function Induces Tumorigenesis

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1998 Jun 20

PMID 9564034

Citations 51

Authors

D R Brown

C A Thomas

S P Deb

Affiliations

Soon will be listed here.

Abstract

The human oncoprotein MDM2 (hMDM2) overexpresses in various human tumors. If amplified, the mdm2 gene can enhance the tumorigenic potential of murine cells. Here, we present evidence to show that the full-length human or mouse MDM2 expressed from their respective cDNA can inhibit the G0/G1-S phase transition of NIH 3T3 and normal human diploid cells. The protein harbors more than one cell-cycle-inhibitory domain that does not overlap with the p53-interaction domain. Deletion mutants of hMDM2 that lack the cell-cycle-inhibitory domains can be stably expressed in NIH 3T3 cells, enhancing their tumorigenic potential. The tumorigenic domain of hMDM2 overlaps with the p53-interaction domain. Some tumor-derived cells, such as Saos-2, H1299 or U-2OS, are relatively insensitive to the growth-inhibitory effects of hMDM2. These observations suggest that hMDM2 overexpression in response to oncogenic stimuli would induce growth arrest in normal cells. Elimination or inactivation of the hMDM2-induced G0/G1 arrest may contribute to one of the steps of tumorigenesis.

Citing Articles

Cucurbitacin B Inhibits the Proliferation of WPMY-1 Cells and HPRF Cells via the p53/MDM2 Axis.

Jin Y, Zhou P, Huang S, Shao C, Huang D, Su X Int J Mol Sci. 2024; 25(17).

PMID: 39273281 PMC: 11395236. DOI: 10.3390/ijms25179333.

The Antiproliferative and Proapoptotic Effects of Cucurbitacin B on BPH-1 Cells via the p53/MDM2 Axis.

Zhou P, Huang S, Shao C, Huang D, Hu Y, Su X Int J Mol Sci. 2024; 25(1).

PMID: 38203613 PMC: 10779356. DOI: 10.3390/ijms25010442.

A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle.

Li H, Dong L, Jin M, Li Q, Wang X, Jia M Molecules. 2023; 28(3).

PMID: 36770809 PMC: 9920120. DOI: 10.3390/molecules28031141.

Evidence supporting the oncogenic role of BAZ1B in colorectal cancer.

Grochowska A, Statkiewicz M, Kulecka M, Cybulska M, Sandowska-Markiewicz Z, Kopczynski M Am J Cancer Res. 2022; 12(10):4751-4763.

PMID: 36381331 PMC: 9641411.

Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain.

Ilic V, Egorova O, Tsang E, Gatto M, Wen Y, Zhao Y Biomolecules. 2022; 12(5).

PMID: 35625571 PMC: 9138535. DOI: 10.3390/biom12050643.

References

Price B, Park S . DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells. Cancer Res. 1994; 54(4):896-9. View

Chen C, Oliner J, Zhan Q, Fornace Jr A, Vogelstein B, Kastan M . Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci U S A. 1994; 91(7):2684-8. PMC: 43434. DOI: 10.1073/pnas.91.7.2684. View

Reifenberger G, Reifenberger J, Ichimura K, Meltzer P, Collins V . Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res. 1994; 54(16):4299-303. View

Florenes V, Maelandsmo G, Forus A, Andreassen A, Myklebost O, Fodstad O . MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. J Natl Cancer Inst. 1994; 86(17):1297-302. DOI: 10.1093/jnci/86.17.1297. View

Juven T, Barak Y, Zauberman A, GEORGE D, Oren M . Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene. 1993; 8(12):3411-6. View

Perry M, Piette J, Zawadzki J, Harvey D, Levine A . The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci U S A. 1993; 90(24):11623-7. PMC: 48036. DOI: 10.1073/pnas.90.24.11623. View

Picksley S, Lane D . The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?. Bioessays. 1993; 15(10):689-90. DOI: 10.1002/bies.950151008. View

Haines D, Landers J, Engle L, GEORGE D . Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol Cell Biol. 1994; 14(2):1171-8. PMC: 358473. DOI: 10.1128/mcb.14.2.1171-1178.1994. View

Lane D, CRAWFORD L . T antigen is bound to a host protein in SV40-transformed cells. Nature. 1979; 278(5701):261-3. DOI: 10.1038/278261a0. View

10.

Linzer D, Levine A . Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell. 1979; 17(1):43-52. DOI: 10.1016/0092-8674(79)90293-9. View

11.

Harlow E, CRAWFORD L, Pim D, Williamson N . Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol. 1981; 39(3):861-9. PMC: 171319. DOI: 10.1128/JVI.39.3.861-869.1981. View

12.

Gorman C, Moffat L, Howard B . Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982; 2(9):1044-51. PMC: 369897. DOI: 10.1128/mcb.2.9.1044-1051.1982. View

13.

Sugden B, Marsh K, Yates J . A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol. 1985; 5(2):410-3. PMC: 366725. DOI: 10.1128/mcb.5.2.410-413.1985. View

14.

Lee W, Shew J, Hong F, SERY T, Donoso L, Young L . The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature. 1987; 329(6140):642-5. DOI: 10.1038/329642a0. View

15.

Masuda H, Miller C, Koeffler H, Battifora H, Cline M . Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A. 1987; 84(21):7716-9. PMC: 299371. DOI: 10.1073/pnas.84.21.7716. View

16.

Band V, Sager R . Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci U S A. 1989; 86(4):1249-53. PMC: 286665. DOI: 10.1073/pnas.86.4.1249. View

17.

Roberts B . Nuclear location signal-mediated protein transport. Biochim Biophys Acta. 1989; 1008(3):263-80. DOI: 10.1016/0167-4781(89)90016-x. View

18.

Shew J, Lin B, Chen P, Tseng B, Yang-Feng T, Lee W . C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc Natl Acad Sci U S A. 1990; 87(1):6-10. PMC: 53188. DOI: 10.1073/pnas.87.1.6. View

19.

Band V, Zajchowski D, Swisshelm K, Trask D, Kulesa V, Cohen C . Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res. 1990; 50(22):7351-7. View

20.

Diller L, Kassel J, Nelson C, Gryka M, Litwak G, Gebhardt M . p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol. 1990; 10(11):5772-81. PMC: 361354. DOI: 10.1128/mcb.10.11.5772-5781.1990. View